Mice were infected with Friend leukemia virus and later immunized with either Vibrio cholerae vaccine or sheep erythrocytes. The primary antibody response to the bacteria (as judged by the number of plaqueforming cells) was slightly enhanced by the viral infection, whereas the response to sheep erythrocytes was inhibited. The difference appeared due to sensitization of mice to antigens crossreacting with those of sheep erythrocytes; no natural immunity to V. cholerae is detectable. However, the response of mice infected with Friend leukemia virus to a secondary challenge with the cholera bacteria was markedly inhibited. Even though the number of plaqueforming cells during the primary response was not reduced, accumulation of the cells in distinct splenic foci was suppressed. These results suggest that the effect of Friend leukemia virus on immunocompetent cells is selective. The immune response appears to be susceptible to leukemia virus-induced immunosuppression only when there has been a previous stimulation of immunocytes by antigen.
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Experimental infection of susceptible mice with RNA murine leukemia viruses resulting in malignant proliferative disease of the reticuloendothelial system is accompanied by a nonspecific inhibition of the immune response to a large number of antigens. Ample evidence has now accumulated in several laboratories concerning such immunosuppression and has recently been reviewed by Notkins et al. (1) . It has been suggested that leukemia virus-induced immunosuppression may be one of the important factors in tumorigenesis, i.e., the generalized impairment of immunity includes the potential immune defense of the individual against the virus itself, virus-induced tumor antigen, or both, thus paving the way for the neoplastic process. However, as shown by the present study, the immunosuppressive effect of murine leukemia viruses may not be as unequivocal as previously believed.
The two antigen models we chose for the comparative studies on FLV-induced immunosuppression, namely, the gram-negative bacterium Vibrio cholerae and sheep erythrocytes, differ in one major aspect. There is a variable but substantial number of "background" plaque-forming cells (PFC) inthe spleen of nonimmunized mice that form antibodies to erythrocytes, resulting probably from continuous sensitization of mice with crossreacting bacterial antigens (2, 3 increase of such "background" PFC, even without inoculation with sheep erythrocytes (4, 5) . On the other hand, there is no detectable "background" to V. cholerae in mice; even vigorous nonspecific stimulation with known stimulators fails to elicit any detectable antibody-forming cells (6, and unpublished data). In contrast to the situation with sheep erythrocytes, the reaction of "virgin" antigen-reactive cells to the first immunization with the cholera bacteria can be considered a true primary response.
Immunity to sheep erythrocytes, as measured by the hemolytic PFC technique, has been widely used in previous studies of the mechanism of immunosuppression during viral leukemogenesis. Infection of mice with FLV before immunization suppressed 90% or more of the subsequent response to sheep erythrocytes in the spleen of mice (7, 8) . Other leukemia viruses had similar effects (1) .
Previous experiments from this laboratory demonstrated that splenic antibody-forming cells differentiate as isolated foci (9) (10) (11) (12) . One focus may contain 50-2000 PFC (11, 12 Fig. 1 . The initial increase of antibacterial and anti-sheep erythrocyte PFC between the second and fourth day after immunization is similar. However, the end of the log phase of the former is followed by a plateau and another slow increase, so that the peak number of antibacterial PFC is not attained until the tenth day.
Assay for splenic foci and areas
The method for detection of antibody foci (12) in sections of frozen spleen was adopted from previous studies with other bacteria (10) . The spleens were frozen rapidly and placed in a cryostat at -180C. Thin longitudinal sections (6-7 Jim thick) were cut and transferred rapidly-inside the cryostatonto test agar plates containing viable bacteria. Incubation of the plates at 370C, followed by treatment with complement, results in focal bacteriolysis under the splenic sections. The sharp foci contrast with the surrounding homogeneous bacterial growth, developed in a few distinct areas of the spleen (Fig. 2) . Comparison of focus distribution in serial sections through the organ permits determination of the number of foci per individual splenic area.
RESULTS
Infection of mice with FLV 4-days before immunization resulted in about 80% suppression in the number of antisheep erythrocyte PFC, as compared with uninfected control mice ( Longitudinal section from the spleen of a mouse immunized with V. cholerae. The section was tested for bacteriolytic activity as described in Methods. Zones of bacteriolytic antibody production appear as sharp foci assembled in three distinct areas of the spleen. Assay of serial sections from the same organ reveals the average number of foci in each area (numbers for this section are 8, 3, and more than 10 foci per area, respectively). injection of vaccine, as were other primed uninfected control mice. Normal mice of the same age (both FLV-infected and uninfected) served as controls of the primary response.
As is evident in Table 3 , the secondary response was suppressed 90% by previous infection with FLV, whereas the primary response was enhanced.
The possible effect of FLV on differentiation of antibodyforming cells in isolated splenic foci was studied in parallel groups of mice immunized with V. cholerae, either FLVinfected or not. PFC were counted in spleens of one group and the number of foci was determined in splenic sections from another group (Table 4 ). The number of detectable splenic foci was about 60% lower than in controls, even though the PFC number in the spleens of the parallel group of mice was unaffected by FLV infection. The number of splenic areas in which the antibody foci and PFC accumulated was also the same in both infected and control spleens.
DISCUSSION
It seems apparent from this study that leukemia virusinduced immunosuppression may not be general for all anti- (15) . The effects of other murine leukemia viruses such as Gross and Moloney virus are being studied in the cholera model system in this laboratory.
The significance of the slight but consistent increase in the antibacterial response during leukemogenesis is difficult to explain. Nevertheless, it seems that a particular antigenreactive cell may replicate together with other cells in the enlarging spleen of an infected mouse. However, an immunoenhancing effect by lactate dehydrogenase virus, which often contaminates Friend-virus preparations, cannot be excluded (16, 17) .
Indirect evidence indicates that the splenic foci of PFC may be created by immunologically specific antigen-reactive cells that differentiate and proliferate into clonal-like formations of antibody-forming cells (11, 12) . This normal function may be suppressed by FLV infection. However, PFC accumulate in the spleen at the same rate. This suggests the interesting possibility that the normally occurring differentiation of antigen-reactive cells to PFC after primary antigenic stimulation may be only a facultative process that is susceptible to diversion to another developmental pathway in the process of leukemogenesis.
This discussion may be relevant to the problem of immunization of an individual against a leukemia virus. If virus infection is accompanied by immunologic sensitization of specific antigen-reactive cells to virus antigen, followed by subsequent inhibition, the possibility of effective immunotherapy would be remote. On the other hand, if the virus first establishes immunological tolerance toward itself or neoantigens (18) , and such tolerance is induced without concomitant immunological sensitization-as has been shown in other experimental systems (19) -the possibility of reversing tolerance and immunizing the individual would be theoretically possible.
